MENU
NRXS
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Neuraxis (NRXS) Ownership - Who owns Neuraxis?
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children... Show more
Profile
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
14.07M
P/E Ratio
N/A
Total Cash
260.89K
Projected Growth
N/A
Total Debt
477.15K
Revenue
2.46M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.04
Total Debt/Equity
N/A
Revenue/Share
0.39 USD as % of share price
Fundamentals
NRXS
Capitalization
14.1M
P/E Ratio
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
261K
Total Cash/Share
0.04
Total Debt
477K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.39%
Revenue
2.46M
ROE
N/A
Book Value
-1.8M
P/B Ratio
6.82
Cash Flow
N/A
Earnings
-0.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
6.98K
Current Ratio
0.24
Current Revenue Per Employee
35085.53
Dividends Per Share - Security
N/A
EBITDA
-8.02M
Float
N/A
Float - Current
N/A
Gross Income Margin
85.44
Revenue To Assets
-704.94
Shares Held By Institutions
1.34M
Shares Outstanding - Current
7.22M
Total Liabilities
2.94M
Total Volume MTD
N/A
Value
N/A
Gain YTD
2.843
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11550 N. Meridian Street
Phone
+1 812 689-0791
Employees
N/A
Web
http://www.neuraxis.com